EML4 and non-small cell lung carcinoma: Although a large number of new fusion partners have been found in ALK fusion gene positive NSCLC, the earliest EML4-ALK fusion form is the most common, accounting for about 85% [16] [17] [18], which is basically consistent with the data in our study.